Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D
- 16 January 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Endocrine
- Vol. 71 (2), 267-269
- https://doi.org/10.1007/s12020-020-02597-7
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19Acta Endocrinologica, 2020
- Vitamin D Status in Hospitalized Patients with SARS-CoV-2 InfectionJournal of Clinical Endocrinology & Metabolism, 2020
- “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”The Journal of Steroid Biochemistry and Molecular Biology, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortalityAging Clinical and Experimental Research, 2020
- The role of Vitamin D in the prevention of Coronavirus Disease 2019 infection and mortalityPublished by Research Square Platform LLC ,2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant dataBMJ, 2017
- Vitamin D and the intracrinology of innate immunityMolecular and Cellular Endocrinology, 2010